Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -30.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.83% |
| Dec 31, 2025 | -3.63% |
| Sep 30, 2025 | 18.59% |
| Jun 30, 2025 | -5.35% |
| Mar 31, 2025 | -52.45% |
| Dec 31, 2024 | -20.95% |
| Sep 30, 2024 | -46.72% |
| Jun 30, 2024 | 12.50% |
| Mar 31, 2024 | 53.86% |
| Dec 31, 2023 | 54.15% |
| Sep 30, 2023 | 66.93% |
| Jun 30, 2023 | 39.25% |
| Mar 31, 2023 | 37.49% |
| Dec 31, 2022 | -36.56% |
| Sep 30, 2022 | -3.76% |
| Jun 30, 2022 | -39.58% |
| Mar 31, 2022 | -35.00% |
| Dec 31, 2021 | -14.99% |
| Sep 30, 2021 | -82.90% |
| Jun 30, 2021 | -15.76% |